ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Plant-Derived Viral Nanoparticles Enable Simultaneous Guidance of Neuronal Cell Outgrowth and Targeting of Neurodifferentiation Pathways.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Plant-Derived Viral Nanoparticles Enable Simultaneous Guidance of Neuronal Cell Outgrowth and Targeting of Neurodifferentiation Pathways.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Differentiating neuronal cells in vitro is a complex process that can be significantly enhanced by using a combination of functional peptides and nanostructured scaffolds in combination. However, applying these elements simultaneously remains challenging. Here, a novel neural tissue engineering approach that uses plant-derived viral nanoparticles (VNPs) to simultaneously promote neuronal differentiation and growth guidance is presented. It is hypothesized that the simultaneous alignment and promotion of neurodifferentiation could be achieved by using genetically engineered potato virus X and tobacco mosaic virus, which display high local concentrations of functional peptides derived from laminin (RGD and IKVAV) and brain-derived neurotrophic factor. Immunostaining, gene analysis, immunoprecipitation, and western blotting are employed to evaluate the effect of VNPs on neurodifferentiation and their mechanism of action via cell membrane receptors. 3D printing with sacrificial materials is used to align the VNPs, as confirmed by scanning electron microscopy. This approach creates an orientated microarchitecture that simultaneously combines growth guidance and pathway targeting. The incorporation of growth-factor-like peptides onto the VNP surface through genetic engineering represents a significant advancement in this area of research. This provides unparalleled control over neural cell differentiation and neurite outgrowth by utilizing plant-derived, bioactive, and biomimetic nanoparticles as a multifunctional scaffold base.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.